{
    "id": 5570,
    "fullName": "PIK3CA E365K",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "PIK3CA E365K lies within the C2 PI3K-type domain of the Pik3ca protein (UniProt.org). E365K is predicted to confer a gain of function to Pik3ca, as indicated by increased phosphorylation of downstream targets Akt, GSK3-beta, FoxO1, FoxO3a, and S6 in cell culture (PMID: 18829572, PMID: 21266528), and in one of two cell lines, increased cell proliferation and cell viability as compared to wild-type Pik3ca (PMID: 29533785).",
            "references": [
                {
                    "id": 2211,
                    "pubMedId": 21266528,
                    "title": "A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21266528"
                },
                {
                    "id": 1933,
                    "pubMedId": 18829572,
                    "title": "PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18829572"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 11238,
                    "pubMedId": 29533785,
                    "title": "Systematic Functional Annotation of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29533785"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5290,
        "geneSymbol": "PIK3CA",
        "terms": [
            "PIK3CA",
            "CLAPO",
            "CLOVE",
            "CWS5",
            "MCAP",
            "MCM",
            "MCMTC",
            "p110-alpha",
            "PI3K",
            "PI3K-alpha"
        ]
    },
    "variant": "E365K",
    "createDate": "04/30/2015",
    "updateDate": "09/14/2018",
    "referenceTranscriptCoordinates": {
        "id": 171693,
        "transcript": "NM_006218",
        "gDna": "chr3:g.179204536G>A",
        "cDna": "c.1093G>A",
        "protein": "p.E365K",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2139,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BEZ235 inhibited proliferation of endometrial cancer cells harboring PIK3CA E365K and PTEN mutations in culture (PMID: 22662154).",
            "molecularProfile": {
                "id": 5401,
                "profileName": "PIK3CA E365K PTEN mut"
            },
            "therapy": {
                "id": 672,
                "therapyName": "BEZ235",
                "synonyms": null
            },
            "indication": {
                "id": 7519,
                "name": "endocervical carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 348,
                    "pubMedId": 22662154,
                    "title": "Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22662154"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2113,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BEZ235 inhibited proliferation of endometrial cancer cells harboring PIK3CA E365K and PTEN mutations in culture (PMID: 22662154).",
            "molecularProfile": {
                "id": 5401,
                "profileName": "PIK3CA E365K PTEN mut"
            },
            "therapy": {
                "id": 672,
                "therapyName": "BEZ235",
                "synonyms": null
            },
            "indication": {
                "id": 1380,
                "name": "endometrial cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 348,
                    "pubMedId": 22662154,
                    "title": "Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22662154"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 5400,
            "profileName": "PIK3CA E365K",
            "profileTreatmentApproaches": [
                {
                    "id": 17362,
                    "name": "PI3K Inhibitor (Pan)",
                    "profileName": "PIK3CA E365K"
                },
                {
                    "id": 17363,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "PIK3CA E365K"
                },
                {
                    "id": 17366,
                    "name": "Akt2 Inhibitor",
                    "profileName": "PIK3CA E365K"
                },
                {
                    "id": 17361,
                    "name": "Akt1 Inhibitor",
                    "profileName": "PIK3CA E365K"
                },
                {
                    "id": 17359,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "PIK3CA E365K"
                },
                {
                    "id": 17364,
                    "name": "Akt Inhibitor (Pan)",
                    "profileName": "PIK3CA E365K"
                },
                {
                    "id": 17365,
                    "name": "PIK3CA inhibitor",
                    "profileName": "PIK3CA E365K"
                },
                {
                    "id": 17360,
                    "name": "mTOR Inhibitor",
                    "profileName": "PIK3CA E365K"
                }
            ]
        },
        {
            "id": 5401,
            "profileName": "PIK3CA E365K PTEN mut",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 171692,
            "transcript": "XM_006713658",
            "gDna": "chr3:g.179204536G>A",
            "cDna": "c.1093G>A",
            "protein": "p.E365K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171693,
            "transcript": "NM_006218",
            "gDna": "chr3:g.179204536G>A",
            "cDna": "c.1093G>A",
            "protein": "p.E365K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171694,
            "transcript": "XM_011512894",
            "gDna": "chr3:g.179204536G>A",
            "cDna": "c.1093G>A",
            "protein": "p.E365K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}